SII and SIRI as Prognostic Biomarkers in Lupus Nephritis

Sponsor
Assiut University
Study ID
NCT07780045
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Study Details

This prospective observational study aims to evaluate the prognostic utility of the Systemic Immune-Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) as novel inflammatory biomarkers for monitoring disease activity and predicting renal progression, flares, and outcomes in patients with lupus nephritis.

Key Dates

First listed
Aug 21, 2026
Start date
Aug 19, 2026
Status verified
Aug 2026
Primary completion
Aug 19, 2027
Completion
Oct 19, 2027

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Correlation of SII and SIRI with disease activity [ Time Frame: Baseline, 6 months, and 12 months ]

Central Contacts

Find similar trials

Nationwide
Lupus (SLE) trialsRheumatology trialsAutoimmune disease trials

Related Studies